Engage Bio develops non-viral DNA medicines for genetic and therapeutic applications.
Engage Bio's investors include Y Combinator, Pioneer Fund, SAV (Scale Asia Ventures), Flybridge, SciFounders.
Engage Bio is headquartered in San Carlos, United States.
Engage Bio develops non-viral DNA medicines for genetic and therapeutic applications.
Engage Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Engage Bio — Funding & Investors." VCBacked, May 1, 2022, https://www.vcbacked.co/company/engage-bio. Accessed July 19, 2026.
VCBacked. (2022). Engage Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/engage-bio
{{cite web |title=Engage Bio — Funding & Investors |url=https://www.vcbacked.co/company/engage-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated